These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10739503)

  • 1. Assessment by quantitative ultrasonometry of the effects of hormone replacement therapy on bone mass.
    Hadji P; Hars O; Schüler M; Bock K; Wüster C; Emons G; Schulz KD
    Am J Obstet Gynecol; 2000 Mar; 182(3):529-34. PubMed ID: 10739503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT).
    Hadji P; Gottschalk M; Ziller V; Kalder M; Jackisch C; Wagner U
    Maturitas; 2007 Mar; 56(3):312-21. PubMed ID: 17049767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of long-term, non-suppressive levothyroxine treatment on quantitative ultrasonometry of bone in women.
    Hadji P; Hars O; Sturm G; Bauer T; Emons G; Schulz KD
    Eur J Endocrinol; 2000 May; 142(5):445-50. PubMed ID: 10802520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pregnancy and breast-feeding on quantitative ultrasonometry of bone in postmenopausal women.
    Hadji P; Ziller V; Kalder M; Gottschalk M; Hellmeyer L; Hars O; Schmidt S; Schulz KD
    Climacteric; 2002 Sep; 5(3):277-85. PubMed ID: 12419086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study.
    Adami S; Giannini S; Giorgino R; Isaia G; Maggi S; Sinigaglia L; Filipponi P; Crepaldi G; Di Munno O
    Osteoporos Int; 2003 May; 14(3):198-207. PubMed ID: 12730794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in measurement of the calcaneus using ultrasonic methods in children and adolescents].
    Jaworski M; Lorenc RS
    Przegl Lek; 2000; 57(2):93-9. PubMed ID: 10907350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadband ultrasound attenuation (BUA) of the heel bone and its correlates in men and women in the EPIC-Norfolk cohort: a cross-sectional population-based study.
    Welch A; Camus J; Dalzell N; Oakes S; Reeve J; Khaw KT
    Osteoporos Int; 2004 Mar; 15(3):217-25. PubMed ID: 14745486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of the height of body mass on ultrasound measurements of bones in healthy Polish women].
    Lorenc S; Glinkowski W; Rydzyński P; Lorenc RS
    Pol Merkur Lekarski; 1998 Oct; 5(28):215-7. PubMed ID: 10101446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three bone ultrasounds for the discrimination of subjects with and without osteoporotic fractures among 7562 elderly women.
    Krieg MA; Cornuz J; Ruffieux C; Sandini L; Büche D; Dambacher MA; Hartl F; Häuselmann HJ; Kraenzlin M; Lippuner K; Neff M; Pancaldi P; Rizzoli R; Tanzi F; Theiler R; Tyndall A; Wimpfheimer K; Burckhardt P
    J Bone Miner Res; 2003 Jul; 18(7):1261-6. PubMed ID: 12854836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and body size: how much does lifestyle explain?
    Luoto R; Männistö S; Vartiainen E
    Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):66-73. PubMed ID: 9465806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Despite a high prevalence of menstrual disorders, bone health is improved at a weight-bearing bone site in world-class female rhythmic gymnasts.
    Maïmoun L; Coste O; Georgopoulos NA; Roupas ND; Mahadea KK; Tsouka A; Mura T; Philibert P; Gaspari L; Mariano-Goulart D; Leglise M; Sultan C
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4961-9. PubMed ID: 24106284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study.
    Jensen LB; Vestergaard P; Hermann AP; Gram J; Eiken P; Abrahamsen B; Brot C; Kolthoff N; Sørensen OH; Beck-Nielsen H; Nielsen SP; Charles P; Mosekilde L
    J Bone Miner Res; 2003 Feb; 18(2):333-42. PubMed ID: 12568411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative ultrasonometry of the phalanges during pregnancy: a longitudinal study.
    Hellmeyer L; Ossendorf A; Ziller V; Tekesin I; Schmidt S; Hadji P
    Climacteric; 2006 Dec; 9(6):446-51. PubMed ID: 17085377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perimenopausal symptoms, quality of life, and health behaviors in users and nonusers of hormone therapy.
    Twiss JJ; Wegner J; Hunter M; Kelsay M; Rathe-Hart M; Salado W
    J Am Acad Nurse Pract; 2007 Nov; 19(11):602-13. PubMed ID: 17970860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women.
    van Baal WM; Kenemans P; Stehouwer CD; Peters-Muller ER; van Vugt JM; van der Mooren MJ
    Am J Obstet Gynecol; 1999 Dec; 181(6):1365-73. PubMed ID: 10601914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy in Germany: determinants and possible health-related outcomes. Results of National Health Surveys from 1984 to 1999.
    Du Y; Melchert HU; Schäfer-Korting M
    Maturitas; 2005; 52(3-4):223-34. PubMed ID: 16040212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between heel ultrasound and hormone replacement therapy is modulated by a two-locus vitamin D and estrogen receptor genotype.
    Giguère Y; Dodin S; Blanchet C; Morgan K; Rousseau F
    J Bone Miner Res; 2000 Jun; 15(6):1076-84. PubMed ID: 10841176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone status in healthy Estonian women assessed with quantitative ultrasonometry.
    Maasalu K; Kirjanen K; Haviko T
    Acta Orthop Scand; 2002 Oct; 73(5):558-61. PubMed ID: 12440500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.